What is Turn Therapeutics Inc. Common Stock (TTRX) stock price today?

Turn Therapeutics Inc. Common Stock (TTRX) currently trades at $3.69 per share. The stock has a market capitalization of $107.24M and a P/E ratio of —x.

Is TTRX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Turn Therapeutics Inc. Common Stock has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is —.

Is Turn Therapeutics Inc. Common Stock financially healthy?

Turn Therapeutics Inc. Common Stock's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of — places it in the —.

TTRX

Turn Therapeutics Inc. Common Stock

NASDAQ: TTRX · HEALTHCARE · BIOTECHNOLOGY

$3.69

+3.81% today

Updated 2026-04-30

Market cap

$107.24M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.12

Dividend yield

—

52W range

$3 – $10

Volume

0.0M

Market cap

$107.24M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.12

Dividend yield

—

52W range

$3 – $10

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.8

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$8.00

+116.78%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.06x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-2.72M

Key financials

Revenue Net Income Free Cash Flow

Metric	2023	2024	2025	TTM
Revenue	$0.00	$0.00	—	—
Net income	$-2.29M	$-1.77M	$-3.19M	$-3.19M
EPS	—	—	—	$-0.12
Free cash flow	$-1.42M	$-1.46M	$-2.72M	$-2.72M
Profit margin	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TTRX	$107.24M	16	4.3	3.0	5.0	6.8	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Turn Therapeutics Inc. Common Stock trades at $3.69. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score.

Frequently asked questions

What is Turn Therapeutics Inc. Common Stock's stock price?

Turn Therapeutics Inc. Common Stock (TTRX) trades at $3.69.

Is Turn Therapeutics Inc. Common Stock overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of Turn Therapeutics Inc. Common Stock (TTRX)?

The analyst target price is $8.00, representing +116.8% upside from the current price of $3.69.

Piotroski F-Score?

1/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-141.70%

Beta—

50D MA$3.44

200D MA$3.95

Shares out0.03B

Float0.01B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

TTRX vs LLY →TTRX vs JNJ →TTRX vs ABBV →Stock screener →